# Acetyl Hexapeptide-8 for Blepharospasm

> **NCT01750346** · PHASE2 · TERMINATED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 8 (actual)

## Conditions studied

- Focal Dystonia

## Interventions

- **DRUG:** Topical acetyl hexapeptide-8
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01750346
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01750346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01750346, "Acetyl Hexapeptide-8 for Blepharospasm". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01750346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*